Glucose Health, Inc. GLUC

Annual Quarterly

No annual revenue total was found in GLUCOSE HEALTH, INC.'s SEC filings.

Glucose Health, Inc. (GLUC) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products.

Revenue
—
Net income (TTM)
$-85,062
+74.5% vs year-ago TTM
Operating cash flow (TTM)
$-17,253
+61.8% vs year-ago TTM
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
3.31M
+30.3% vs prior year
Net cash
—
Operating margin
—

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
GLUC (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bentonville, AR
SEC filer status
Smaller reporting company
SEC CIK
1420108
Former names
Bio-Solutions Corp. (until Dec 16, 2014)

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

FY 2016
Dec 31, 2016
FY 2015
Dec 31, 2015
FY 2014
Dec 31, 2014
FY 2013
Dec 31, 2013
FY 2012
Dec 31, 2012
Operating income
-$86,647
-$156,173
-$545,216
-$1.3M
-$361,423
Net income
-$410,443
-$266,064
-$669,409
-$1.5M
-$399,078
Operating cash flow
-$39,263
-$115,776
-$135,352
-$131,985
-$83,691
Total assets
$33,145
$15,407
$44,030
$25,590
$207,676
Total liabilities
$528,592
$403,226
$324,582
$223,348
$185,476
Stockholders' equity
-$495,447
-$387,819
-$280,552
-$197,758
$22,200
Cash and investments
$20,542
$2,055
—
$711
$1,076

Recent SEC filings

Form Description Filed Period
10-Q Quarterly report Nov 14, 2017 Sep 30, 2017
10-Q Quarterly report Aug 21, 2017 Jun 30, 2017
10-Q Quarterly report May 15, 2017 Mar 31, 2017
8-K Current report
Auditor change
 Apr 11, 2017 Apr 6, 2017
10-K Annual report Mar 29, 2017 Dec 31, 2016
10-Q Quarterly report Dec 21, 2016 Sep 30, 2016

All 140 Glucose Health, Inc. SEC filings

Source: SEC EDGAR filings. This is company-reported data, not investment advice.